New synthetic approach to atypical retinoids: application of a versatile annulation procedure

Tetrahedron

Volumn 63, Issue 10, 2007, Pages 2351-2356

  Brenna, Elisabetta ^a   Fuganti, Claudio ^a   Fronza, Giovanni ^a   Gatti, Francesco G ^a   Sala, Federico ^a   Serra, Stefano ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

Annulation; Atypical retinoids; Benzene ring; Cancer therapy

Indexed keywords

3 (3 ADAMANTANYL 4 BENZYLOXYPHENYL)ACRYLALDEHYDE; 3 (3 ADAMANTYL 4 BENZYLOXYPHENYL)PROP 2 EN 1 OL; 3 [2 (3 ACETAMIDOPROPOXY) 5' ADAMANTYL 4' HYDROXYBIPHENYL 4 YL]ACRYLIC ACID; 3 ADAMANTANYL 2' [3 (1,3 DIOXOISOINDOLIN 2 YL)PROPOXY] 4' FORMYLBIPHENYL 4 YLACETATE; 3 ADAMANTYL 2' [3 (1 HYDROXY 3 OXOISOINDOLIN 2 YL)PROPOXY] 4' HYDROXYMETHYLBIPHENYL 4 YLACETATE; 3 ADAMANTYL 4 BENZYLOXYBENZALDEHYDE; 3 ADAMANTYL 4 HYDROXYBENZALDEHYDE; 4' ACETOXY 5' ADAMANTYL 2 [3 (1,3 DIOXOISOINDOLIN 2 YL)PROPOXY]BIPHENYL 4 CARBOXYLIC ACID; 6 (3 ADAMANTYL 4 BENZYLOXYPHENYL) 3 ETHOXYCARBONYLHEXA 3,5 DIENOIC ACID; BROMOACETIC ACID; CARBON; ETHYL 3 (3 ADAMANTYL 4 BENZYLOXYPHENYL)ACRYLATE; ETHYL 3 [4' ACETOXY 5' ADAMANTYL 2 [3 (1,3 DIOXOISOINDOLIN 2 YL)PROPOXY]BIPHENYL 4 YL]ACRYLATE; ETHYL 5' ADAMANTANYL 2 [3 (1,3 DIOXOISOINDOLIN 2 YL)PROPOXY] 4' HYDROXYBIPHENYL 4 CARBOXYLATE; ETHYL 5' ADAMANTANYL 4' BENZYLOXY 2 [3 (1,3 DIOXOISOINDOLIN 2 YL)PROPOXY]BIPHENYL 4 CARBOXYLATE; ETHYL 5' ADAMANTANYL 4' BENZYLOXY 2 HYDROXYBIPHENYL 4 CARBOXYLATE; PHOSPHORANE DERIVATIVE; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

ANNULATION REACTION; ARTICLE; ATOM; DRUG SYNTHESIS; PRIORITY JOURNAL;

EID: 33846621881     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2006.12.038     Document Type: Article

References (14)

1. Altucci L., and Gronemeyer H. Nat. Rev. Cancer 1 (2001) 181-193
2. Holmes W.F., Dawson M.I., Soprano R.D., and Soprano K.J. J. Cell Physiol. 185 (2000) 61-67
3. Sun S.Y., Yue P., Ghong W.K., and Lotan R. Cancer Res. 60 (2000) 6537-6543
4. Dawson M.I., Hobbs P.D., Peterson V.J., Leid M., Lange C.W., Feng K., Chen G., Gu J., Li H., Kumar Kolluri S., Zhang X., Zhang Y., and Fontana J.A. Cancer Res. 61 (2001) 4723-4730
5. Miyaura A., and Suzuki A. Chem. Rev. 95 (1995) 2457-2483
6. Charpentier B., Bernardon J.M., Eustache J., Millois C., Martin B., Michel S., and Shroot B. J. Med. Chem. 38 (1995) 4993-5006
7. Shroot, B.; Eustache, J.; Bernardon, J. M. U.S. Patent 4,717,720, 1988.
8. Shroot, B.; Eustache, J.; Bernardon, J. M. EP 199636 B1, 1989.
9. Liu Z., and Xiang J. Org. Process Res. Dev. 10 (2006) 285-288
10. Brenna E., Fuganti C., Perozzo V., and Serra S. Tetrahedron 53 (1997) 15029-15040
11. Brenna E., Scaramelli L., and Serra S. Synlett (2000) 357-358
12. Dawson M.I., Harris D.L., Liu G., Hobbs P.D., Lange C.W., Jong L., Bruey-Sedano N., James S.Y., Zhang X., Peterson V.J., Leid M., Farhana L.A., Rishi K., and Fontana J.A. J. Med. Chem. 47 (2004) 3518-3536
13. Röder E., and Krauss H. Liebigs Ann. Chem. (1992) 177-181
14. Kuang Y., Huang J., and Chen F. Synth. Commun. 36 (2006) 1515-1519